Atin Tablet (Azelaastine Hydrochloride)

Adult dose

As azelastine hydrochloride, administer 1 mg once; for bronchial asthma, administer 2 mg once, twice a day after breakfast and before bedtime. Adjust dosage appropriately based on age and symptoms.

This medication should not be used in children under 6 years of age. This medication contains lactose, so individuals with galactose intolerance, Lapp lactase deficiency, or glucose-galactose malabsorption syndrome should not take it. Taking this medication may cause neurological symptoms such as drowsiness, fatigue, numbness in the limbs, and stumbling. Gastrointestinal symptoms may include dry mouth, nausea, vomiting, cough in the mouth, loss of appetite, abdominal pain, constipation, diarrhea, and gastric discomfort. Facial flushing and shortness of breath may rarely occur. Nasal dryness may occur, and liver function test values may temporarily increase. If a hypersensitivity reaction such as a skin rash occurs, the medication should be discontinued immediately. Difficult urination or symptoms such as hematuria and frequent urination may rarely occur. Blood abnormalities, such as leukocytosis, may also occur infrequently. Swelling or menstrual irregularities may occur, so caution is necessary. This medication may cause drowsiness, so driving or operating hazardous machinery should be avoided while taking it. Patients receiving long-term steroid treatment should gradually and cautiously reduce steroid use when taking this medication. Bronchial asthma patients should understand that this medication is not intended to provide immediate relief for existing attacks. Seasonal allergy patients are advised to start taking the medication before symptoms worsen and to continue taking it throughout the duration of symptoms. Caution is needed when consuming alcohol as it may enhance sedative effects, and careful consideration is required when taken with cimetidine. Pregnant women or those who may become pregnant should use this medication only if the therapeutic benefits are deemed greater than the risks. This medication may be passed through breast milk, so nursing mothers should avoid taking it if possible or discontinue breastfeeding while taking it. Safety in premature infants, newborns, infants, and young children has not been sufficiently established, so caution is warranted. Elderly individuals may have reduced bodily function; therefore, dosage should be reduced or used with caution. This medication may have a bitter taste, so caution is needed during administration. Keep out of reach of children, and store in a cool, dry place away from direct sunlight. Do not transfer to another container to maintain quality.

Serious side effects

Shortness of breath, swelling, increased transaminase activity (elevated AST, ALT, Al-P)

Mild side effects

• Drowsiness
• fatigue
• limb paralysis
• stumbling
• dry mouth
• nausea
• vomiting
• cough in the mouth
• loss of appetite
• abdominal pain

This medication should be stored in an opaque container that prevents air passage and kept at room temperature between 1 and 30 degrees Celsius.

Appearance

Bright yellow round film-coated tablets

Package unit

30 tablets/bottle, 300 tablets/bottle